TREATMENT PATTERNS, HEALTHCARE RESOURCE USE, AND COSTS AMONG US PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR MUTATED (EGFRm) METASTATIC NON-SMALL CELL LUNG CANCER (mNSCLC) AFTER DISCONTINUATION OF OSIMERTINIB

被引：0
|
作者：
Moore-Schiltz, L. [1 ]
McMorrow, D. [2 ]
Chambers, J. [1 ]
Pulungan, Z. [1 ]
Teigland, C. [1 ]
Marrett, L. [3 ]
机构：
[1] Inovalon, Bowie, MD USA
[2] Inovalon, Scarborough, ME USA
[3] Daiichi Sankyo Inc, Basking Ridge, NJ USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE371
引用
收藏
页码：S125 / S126
页数：2
相关论文
共 50 条
  • [1] REAL-WORLD HEALTHCARE RESOURCE USE, COSTS, AND TREATMENT PATTERNS IN ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS WITH DIFFERENT EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION TYPES
    Vadagam, P.
    Chen, J.
    Lee, I
    Tian, D.
    Waters, D. D.
    Near, A.
    Lyle, D.
    Vanderpoel, J.
    VALUE IN HEALTH, 2023, 26 (06) : S86 - S86
  • [2] Osimertinib a new weapon in epidermal growth factor receptor-mutated non-small cell lung cancer patients
    Rossi, Antonio
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S610 - S613
  • [3] Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer
    Gregorc, Vanesa
    Lazzari, Chiara
    Karachaliou, Niki
    Rosell, Rafael
    Santarpia, Mariacarmela
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S165 - S170
  • [4] Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy
    Lazzari, Chiara
    Gregorc, Vanesa
    Santarpia, Mariacarmela
    JOURNAL OF THORACIC DISEASE, 2019, 11 (11) : 4400 - 4403
  • [5] Tumor evolution in epidermal growth factor receptor mutated non-small cell lung cancer
    Velazquez, Ana, I
    McCoach, Caroline E.
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2896 - 2909
  • [6] Epidermal Growth Factor Receptor Mutated Advanced Non-Small Cell Lung Cancer: A Changing Treatment Paradigm
    Pakkala, Suchita
    Ramalingam, Suresh S.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 83 - +
  • [7] Osimertinib-Induced Myositis in a Patient With Metastatic Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation
    Ram, Aatma
    Siu, Chun T.
    Mukherjee, Abir
    Gupta, Ranju
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [8] Tyrosine Kinase Inhibitor (TKI) Real-World Use in Epidermal Growth Factor Receptor Mutated (EGFRm) Advanced Non-small Cell Lung Cancer (NSCLC) Patients
    Minatta, Jose
    Samol, Jens
    Moiseenko, Fedor
    Demedts, Ingel
    Kozlov, Vadim
    Mark, Michael
    Rajappa, Senthil
    Kahangire, Doreen A.
    Madondo, Mutsa
    Bailey, Tom
    Wallis, Hannah
    Erman, Mustafa
    Zukin, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S9 - S9
  • [9] The role of osimertinib in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer
    Liam, Chong-Kin
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S448 - S452
  • [10] Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer Patients
    Gentili, Nicola
    Balzi, William
    Foca, Flavia
    Danesi, Valentina
    Altini, Mattia
    Delmonte, Angelo
    Bronte, Giuseppe
    Crino, Lucio
    De Luigi, Nicoletta
    Mariotti, Marita
    Verlicchi, Alberto
    Burgio, Marco Angelo
    Roncadori, Andrea
    Burke, Thomas
    Massa, Ilaria
    CANCERS, 2024, 16 (03)
12345